0
     

Report Added
Report already added
2022 India Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline

2022 India Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report provides test volume and sales forecasts; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Table of Contents

I. Introduction
II. Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Blood Group Genotyping
3. Infectious Disease Screening Tests
a. AIDS
b. Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis D (Delta Agent)
c. Cytomegalovirus
d. Syphilis
e. West Nile Virus
f. Parvovirus B19
g. Creutzfeldt-Jakob’s Disease
h. Malaria
i. Chagas Disease
j. Babesiosis
4. Pathogen Reduction
5. Leukocyte Reduction
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Automated
and Semiautomated Analyzers
C. Major In Vitro Diagnostic Technologies
and Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
III. Market Size and Growth: Volume and Sales Forecasts for 40 Blood
Typing, Grouping and Infectious Disease Screening Tests
IV. Major Product Development Opportunities
A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher

List of Tables
Executive Summary Table: Total Blood Bank
Test Volume and Reagent Sales
Forecast by Test Category
All Market Segments Blood Typing
And Grouping Test Volume Forecast
All Market Segments Infectious
Disease Screening Test Volume Forecast
All Market Segments Blood Typing
And Grouping Reagent Market
Forecast by Major Test
All Market Segments Infectious
Disease Screening Reagent Market
Forecast by Test
Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or
Marketing HLA Typing Tests
Major Companies Developing or
Marketing AIDS Tests
Major Companies Developing or
Marketing Hepatitis Tests
Major Companies Developing or
Marketing CMV Tests
Major Companies Developing or
Marketing Syphilis Tests
Major Companies Developing or
Marketing Blood Bank Analyzers

Report Title: 2022 India Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW